HCRN-GU23-626

Hispanic/Latino and non-Hispanic BlAck patients treated with niRaparib and abiraterone acetate plus prednisone for Metastatic hOrmone sensitive prostate cancer with deleterious homologous recombinatioN repair alterations: a phase II, open label studY (HARMONY)

 

Status

Currently Enrolling

Cancer Type(s)

Trial Locations

All sites in which the trial HCRN-GU23-626 being conducted in.